Appears on
Articles2
Oversight of Laboratory Developed Tests One Year After ACLA v. FDA: Assessing Legislative Proposals in Context
Our latest Advisory examines the current state of laboratory developed test oversight, highlights key developments since the court’s decision, and explores what stakeholders should be watching as policymakers consider future regulatory approaches.
0
News & Perspectives2d agoFDA Proposes Expedited Investigational New Drug Pilot Program to Drive Early Phase Clinical Research in the United States
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) unveiled Operation TrialBlazer, a department-wide effort to accelerate clinical research and development centered in the United States.[[N:U.S. Dep’t of Health & Human Servs., Operation TrialBlazer (June 2026); U.S. Dep’t of Health & Human Servs., Press Release, HHS Launches Unprecedent
0
News & Perspectives17d ago